The immunogenicity of intradermal influenza vaccination in COPD patients

Vaccine

Volumn 28, Issue 24, 2010, Pages 4045-4051

  Chuaychoo, Benjamas ^a   Wongsurakiat, Phunsup ^a   Nana, Arth ^a   Kositanont, Uraiwan ^a   Maranetra, Khun Nanta ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

COPD; Influenza vaccine; Intradermal

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; TREATMENT RESPONSE; VIRION; VIRUS STRAIN; VIRUS TITRATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIBODY FORMATION; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 77952674091     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.006     Document Type: Article

References (31)

1. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 6 (2007) 532-555
2. Wongsurakiat P., Lertakyamanee J., Maranetra K.N., Jongriratanakul S., and Sangkaew S. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients. J Med Assoc Thai 86 6 (2003) 497-508
3. Wongsurakiat P., Maranetra K.N., Wasi C., Kositanont U., Dejsomritrutai W., and Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 125 6 (2004) 2011-2020
4. Nichol K.L., Margolis K.L., Wuorenma J., and Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 331 12 (1994) 778-784
5. World Health Organization. Global pandemic influenza action plan to increase vaccine supply (2006). http://www.who.int/vaccines-documents/DocsPDF06/863.pdf Available at: www.who.int/vaccines-documents/DocsPDF06/863.pdf
6. World Health Organization. Global pandemic influenza action plan to increase vaccine supply: progress report (2008). http://www.who.int/vaccine_research/Global_Pandemic_Influenza.pdf Available at: www.who.int/vaccine_research/Global_Pandemic_Influenza.pdf
7. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
8. Kupper T.S., and Fuhlbrigge R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 4 3 (2004) 211-222
9. Randolph G.J., Angeli V., and Swartz M.A. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 5 8 (2005) 617-628
10. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., Van Hoecke C., et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351 22 (2004) 2286-2294
11. Beran J., Ambrozaitis A., Laiskonis A., Mickuviene N., Bacart P., Calozet Y., et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 7 (2009) 13
12. Kenney R.T., Frech S.A., Muenz L.R., Villar C.P., and Glenn G.M. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 351 22 (2004) 2295-2301
13. Kunzi V., Klap J.M., Seiberling M.K., Herzog C., Hartmann K., Kursteiner O., et al. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration. Vaccine 27 27 (2009) 3561-3567
14. Leroux-Roels I., Vets E., Freese R., Seiberling M., Weber F., Salamand C., et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine 26 51 (2008) 6614-6619
15. Van Damme P., Oosterhuis-Kafeja F., Van der Wielen M., Almagor Y., Sharon O., and Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27 3 (2009) 454-459
16. Praditsuwan R., Assantachai P., Wasi C., Puthavatana P., and Kositanont U. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community. J Med Assoc Thai 88 2 (2005) 256-264
17. Deng Y., Jing Y., Campbell A.E., and Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 172 6 (2004) 3437-3446
18. Goodwin K., Viboud C., and Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24 8 (2006) 1159-1169
19. Arnou R., Icardi G., De Decker M., Ambrozaitis A., Kazek M.P., Weber F., et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 27 52 (2009) 7304-7312
20. Holland D., Booy R., De Looze F., Eizenberg P., McDonald J., Karrasch J., et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 198 5 (2008) 650-658
21. World Health Organization. WHO recommendations on rabies postexposure treatment and the correct technique of intradermal immunization against rabies (1996), WHO/EMC.ZOO
22. Puri N., Weyand E.H., Abdel-Rahman S.M., and Sinko P.J. An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems. Vaccine 18 23 (2000) 2600-2612
23. Auewarakul P., Kositanont U., Sornsathapornkul P., Tothong P., Kanyok R., and Thongcharoen P. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 25 4 (2007) 659-663
24. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonization of requirements for influenza vaccines (CPMP/BWP/214/96). European Agency for the Evaluation of Medicinal Products; 12 March 1997.
25. Diepersloot R.J., Bouter K.P., Beyer W.E., Hoekstra J.B., and Masurel N. Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus. Diabetologia 30 6 (1987) 397-401
26. Feery B.J., Hartman L.J., Hampson A.W., and Proietto J. Influenza immunization in adults with diabetes mellitus. Diabetes Care 6 5 (1983) 475-478
27. McElhaney J.E., Pinkoski M.J., Au D., Lechelt K.E., Bleackley R.C., and Meneilly G.S. Helper and cytotoxic T lymphocyte responses to influenza vaccination in healthy compared to diabetic elderly. Vaccine 14 6 (1996) 539-544
28. Pozzilli P., Gale E.A., Visalli N., Baroni M., Crovari P., Frighi V., et al. The immune response to influenza vaccination in diabetic patients. Diabetologia 29 12 (1986) 850-854
29. Khawplod P., Wilde H., Sirikwin S., Benjawongkulchai M., Limusanno S., Jaijaroensab W., et al. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Vaccine 24 16 (2006) 3084-3086
30. Khawplod P., Wilde H., Tepsumethanon S., Limusanno S., Tantawichien T., Chomchey P., et al. Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin. Clin Infect Dis 35 12 (2002) 1562-1565
31. Laurent P.E., Bonnet S., Alchas P., Regolini P., Mikszta J.A., Pettis R., et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 25 52 (2007) 8833-8842